Literature DB >> 8761342

Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease.

M Hayn1, K Kremser, N Singewald, N Cairns, M Nemethova, B Lubec, G Lubec.   

Abstract

It has been proposed that the pathogenesis of Down's Syndrome (DS) involves reactive oxygen species (ROS) arising from a gene dosage effect that disproportionately elevates superoxide dismutase (SOD1) activity. It was also suggested that generation of ROS might be responsible for neuronal death in Alzheimer's Disease (AD). Little data on brain ROS in DS and AD exist; therefore, we determined activities of choline acetyltransferase (ChAT) and of the oxidative defense enzymes SOD1 and glutathione peroxidase (GSHPx) in frontal cortex of aged patients with DS and AD. We also measured levels of malondialdehyde, which reflects lipid peroxidation, and o-tyrosine, which represents the hydroxyl radical attack. ChAT was significantly reduced in cortex of patients with DS (-68%) and AD (-66%) as compared to controls. There were no statistically significant differences, however, between controls and both neurodegenerative disorders for SOD1, GSHPx, malondialdehyde and o-tyrosine. Our data contradict the only previous finding on increased SOD1 and ROS in brains of patients with DS: age as well as methodological differences might account for the discrepancy. In conclusion, no evidence for a pathogenetic role of SOD1, GSHPx, lipid peroxidation or hydroxyl radical attack in aged patients with DS and AD could be provided.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761342     DOI: 10.1016/0024-3205(96)00334-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Transcription and activity of antioxidant enzymes after ionizing irradiation in radiation-resistant and radiation-sensitive mice.

Authors:  R Hardmeier; H Hoeger; S Fang-Kircher; A Khoschsorur; G Lubec
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Nitration of tau protein is linked to neurodegeneration in tauopathies.

Authors:  Takashi Horiguchi; Kunihiro Uryu; Benoit I Giasson; Harry Ischiropoulos; Richard LightFoot; Christine Bellmann; Christiane Richter-Landsberg; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

3.  Acceleration of the development of Alzheimer's disease in amyloid beta-infused peroxiredoxin 6 overexpression transgenic mice.

Authors:  Hyung-Mun Yun; Peng Jin; Jin-Yi Han; Moon-Soon Lee; Sang-Bae Han; Ki-Wan Oh; Sung-Han Hong; Eun-Yong Jung; Jin Tae Hong
Journal:  Mol Neurobiol       Date:  2013-06-15       Impact factor: 5.590

4.  Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

Authors:  K J H Robson; D J Lehmann; V L C Wimhurst; K J Livesey; M Combrinck; A T Merryweather-Clarke; D R Warden; A D Smith
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

Review 5.  Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.

Authors:  Xinglong Wang; Wenzhang Wang; Li Li; George Perry; Hyoung-gon Lee; Xiongwei Zhu
Journal:  Biochim Biophys Acta       Date:  2013-11-01

6.  Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology.

Authors:  John H T Power; Sana Asad; Tim K Chataway; Fariba Chegini; James Manavis; James A Temlett; Poul H Jensen; Peter C Blumbergs; Wei-Ping Gai
Journal:  Acta Neuropathol       Date:  2008-04-02       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.